Gene: C19orf85
Official Full Name: chromosome 19 open reading frame 85provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19137 | C19orf85 Knockout cell line (HeLa) | Human | C19orf85 | 1:3~1:6 | Negative | Online Inquiry |
KO19138 | C19orf85 Knockout cell line (HCT 116) | Human | C19orf85 | 1:2~1:4 | Negative | Online Inquiry |
KO19139 | C19orf85 Knockout cell line (A549) | Human | C19orf85 | 1:3~1:4 | Negative | Online Inquiry |
C19orf85 Gene Knockout Cell Lines represent a cutting-edge tool utilized in molecular biology and genetic research to investigate the functions and pathways associated with the C19orf85 gene. This gene, known to participate in various cellular processes, including cell proliferation and differentiation, has garnered interest in studies related to cancer and developmental biology. The knockout cell lines provide researchers with a vital system to elucidate the role of C19orf85 by allowing the precise manipulation of the gene's expression.
These cell lines utilize state-of-the-art CRISPR-Cas9 gene-editing technology to introduce targeted deletions in the C19orf85 locus, resulting in the complete ablation of gene function. The mechanisms at play involve the creation of double-strand breaks in the DNA, which the cell repairs inaccurately, leading to frameshift mutations. This knockout strategy enables the assessment of phenotypic changes, cellular signaling alterations, and the investigation of compensatory mechanisms that may arise due to the absence of C19orf85.
The significance of C19orf85 Gene Knockout Cell Lines in research contexts cannot be overstated. They offer indispensable insights that aid in understanding disease mechanisms, particularly in oncological studies and genetic disorders. In clinical settings, they serve as preclinical models for evaluating therapeutic interventions and biomarker discoveries, thus playing a pivotal role in translational medicine.
Compared to traditional knockdown methods, such as RNA interference, knockout cell lines allow for permanent and heritable gene disruption, resulting in more robust and reproducible experimental outcomes. Additionally, our product is validated for multiple cell types, offering versatility and expanding its application range.
This product is an invaluable resource for researchers and clinicians seeking to advance their understanding of genetic regulation and its implications in health and disease. Leveraging our expertise in genetic engineering and cell line customization, our company is committed to providing reliable, high-quality tools that empower scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.